Carl Zeiss Meditec AG

AFXA

Company Profile

  • Business description

    Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

  • Contact

    Goschwitzer Strasse 51-52
    JenaTH07745
    DEU

    T: +49 3641220115

    https://www.zeiss.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    5,798

Stocks News & Analysis

stocks

AMD: We’re pleased with Anthropic Partnership ahead of advancing AI event

We’re encouraged that AMD will count Anthropic as a third leading AI customer, in addition to OpenAI and Meta.
stocks

The most popular ASX trades in FY26

A closer look at the stocks and ETFs that captured Aussie investors’ attention in FY26.
stocks

Chart of the Week: The CBA chart you can’t ignore

Where value remains in Australian banks.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,018.1041.40-0.46%
CAC 408,346.2491.65-1.09%
DAX 4025,001.29154.12-0.61%
Dow JONES (US)52,218.586.06-0.01%
FTSE 10010,695.6621.31-0.20%
HKSE25,210.81318.151.28%
NASDAQ25,690.90146.30-0.57%
Nikkei 22566,422.60307.000.46%
NZX 50 Index13,795.3132.130.23%
S&P 5007,498.9610.24-0.14%
S&P/ASX 2008,839.0038.60-0.43%
SSE Composite Index3,876.789.740.25%

Market Movers